Regulation of CD8+ T Cells Undergoing Primary and Secondary Responses to Infection in the Same Host
Overview
Affiliations
Naive Ag-specific CD8(+) T cells expand, contract, and become memory cells after infection and/or vaccination. Memory CD8(+) T cells provide faster, more effective secondary responses against repeated exposure to the same pathogen. Using an adoptive transfer system with low numbers of trackable nontransgenic memory CD8(+) T cells, we showed that secondary responses can be comprised of both primary (naive) and secondary (memory) CD8(+) T cells after bacterial (Listeria monocytogenes) and/or viral (lymphocytic choriomeningitis virus) infections. The level of memory CD8(+) T cells present at the time of infection inversely correlated with the magnitude of primary CD8(+) T cell responses against the same epitope but directly correlated with the level of protection against infection. However, similar numbers of Ag-specific CD8(+) T cells were found 8 days postinfection no matter how many memory cells were present at the time of infection. Rapid contraction of primary CD8(+) T cell responses was not influenced by the presence of memory CD8(+) T cells. However, contraction of secondary CD8(+) T cell responses was markedly prolonged compared with primary responses in the same host mice. This situation occurred in response to lymphocytic choriomeningitis virus or L. monocytogenes infection and for CD8(+) T cell responses against multiple epitopes. The delayed contraction of secondary CD8(+) T cells was also observed after immunization with peptide-coated dendritic cells. Together, the results show that the level of memory CD8(+) T cells influences protective immunity and activation of naive precursors specific for the same epitope but has little impact on the magnitude or program of the CD8(+) T cell response.
Moioffer S, Berton R, McGonagill P, Jensen I, Griffith T, Badovinac V J Immunol. 2022; 210(2):168-179.
PMID: 36480268 PMC: 9840817. DOI: 10.4049/jimmunol.2200676.
Lanfermeijer J, Nuhn M, Emmelot M, Poelen M, van Els C, Borghans J Vaccines (Basel). 2021; 9(12).
PMID: 34960178 PMC: 8707000. DOI: 10.3390/vaccines9121431.
Shaw T, Haley M, Dookie R, Godfrey J, Cheeseman A, Strangward P Immunology. 2021; 164(4):737-753.
PMID: 34407221 PMC: 8561116. DOI: 10.1111/imm.13405.
Girel S, Arpin C, Marvel J, Gandrillon O, Crauste F Front Immunol. 2019; 10:230.
PMID: 30842771 PMC: 6392104. DOI: 10.3389/fimmu.2019.00230.
Shehata H, Khan S, Chen E, Fields P, Flavell R, Sanjabi S Proc Natl Acad Sci U S A. 2018; 115(38):E8939-E8947.
PMID: 30126987 PMC: 6156615. DOI: 10.1073/pnas.1808320115.